Volume 18, Number 10—October 2012
Attributing Cause of Death for Patients with Clostridium difficile Infection
Highlight and copy the desired format.
|EID||Gilca R, Frenette C, Thériault N, Fortin É, Villeneuve J. Attributing Cause of Death for Patients with Clostridium difficile Infection. Emerg Infect Dis. 2012;18(10):1707-1708. https://dx.doi.org/10.3201/eid1810.120202|
|AMA||Gilca R, Frenette C, Thériault N, et al. Attributing Cause of Death for Patients with Clostridium difficile Infection. Emerging Infectious Diseases. 2012;18(10):1707-1708. doi:10.3201/eid1810.120202.|
|APA||Gilca, R., Frenette, C., Thériault, N., Fortin, É., & Villeneuve, J. (2012). Attributing Cause of Death for Patients with Clostridium difficile Infection. Emerging Infectious Diseases, 18(10), 1707-1708. https://dx.doi.org/10.3201/eid1810.120202.|
To the Editor: Hota et al. report that for deceased patients who had Clostridium difficile infection (CDI), agreement is poor between causes of death reported on death certificates and those categorized by a review panel (1). Our data support the difficulty of attributing cause of death for patients with CDI.
In 2004 in Quebec, Canada, a mandatory CDI surveillance program was implemented. Deaths that occurred within 30 days after CDI diagnosis were classified as 1) directly attributable to CDI (e.g., toxic megacolon, septic shock), 2) having a CDI contribution (e.g., acute decompensation of chronic heart failure), or 3) unrelated to CDI (e.g., terminal cancer) (2). To determine accuracy of the surveillance classifications, we compared cause-of-death classification of 22 deceased CDI patients reported to surveillance by 1 hospital in 2007 with causes of death reported by 13 external reviewers who examined summaries of medical files of the deceased patients. Reviewers were 11 infectious disease and 2 public health physicians involved with CDI surveillance at their respective hospitals but not this hospital. The median (minimal, maximal) κ statistics for comparison of external reviews with surveillance classification were 0.495 (0.252, 0.607) for directly attributable, 0.182 (−0.091, 0.182) for contributed, and 0.321 (0.124, 0.614) for unrelated. Comparison within external reviewers yielded 0.697 (0.394, 1.0), 0.233 (−0.294, 0.703), and 0.542 (0.154, 0.909), respectively. Complete agreement was found for only 6 cases (4 directly attributable and 2 unrelated) (Figure).
Variation among reviewers suggested that categorizations reported to surveillance were inaccurate. Number of deaths among patients with CDI, regardless of the cause of death, seemed to better indicate CDI severity. Since 2008, only the crude numbers of deaths, not subjected to individual interpretation, have been reported to surveillance. A questionnaire addressing concurrent medical conditions, prognosis, level of care, and circumstances of death is being implemented in Quebec hospitals participating in CDI surveillance and should help determine the role of CDI in deaths.
- Hota SS, Achonu C, Crowcroft NS, Harvey BJ, Lauwers A, Gardam MA. Determining mortality rates attributable to Clostridium difficile infection. Emerg Infect Dis. 2012;18:305–7.
- Gilca R, Fortin E, Hubert B, Frenette C, Gourdeau M. Surveillance of Clostridium difficile–associated diarrhea in Quebec. Report for August 22, 2004, to August 20, 2005 [in French]. Québec: Institut National de Santé Publique du Québec; 2005. p. 4 [cited 2012 Jul 20]. http://www.inspq.qc.ca/pdf/publications/434-BilanCdifficile-22aout2004-20aout2005.pdf
- Figure. . Classification of cause of death among 22 patients with Clostridium difficile infection (CDI), by 13 external reviewers, Quebec, Canada, 2007. Bars indicate the number of reviewers who assigned each...
Please use the form below to submit correspondence to the authors or contact them at the following address:
Rodica Gilca, Institut National de Santé Publique du Québec, 2400 d’Estimauville, Québec City, Québec, Canada, G1E 7G9
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: September 18, 2012
- Page last updated: September 18, 2012
- Page last reviewed: September 18, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)